Product logins

Find logins to all Clarivate products below.


Pulmonology Devices | Market Insights | US | 2021

​In 2020, the US pulmonology device market will be moderately impacted by the COVID-19 pandemic but will nevertheless grow over the forecast period, fueled by bronchoscopy procedure volume growth, favorable demographic trends, and the adoption of premium-priced technologies, particularly in the bronchoscope market. However, a lack of product innovation and minimal procedure volume growth in some pulmonology device market segments will limit the growth of the overall pulmonology device market.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for pulmonology devices in the US across a 10-year period.

Related Medtech Insights Reports

Report
ENT Devices – Market Insights – United States
The US ENT device market will grow modestly over the forecast period, with the nasal packing and myringotomy/tympanostomy device segments seeing the fastest growth rates. The market will be…
Report
Gastrointestinal Endoscopy Devices – Market Insights – United States
The US GI endoscopy device market is projected to experience modest expansion through 2034. The market growth is being driven by supportive treatment and screening guidelines, the growing use of AI…
Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Asia Pacific
The GI endoscopy device market will continue to grow moderately throughout the forecast period, supported by the high incidence of gastric cancer and CRC cases in the region. Growth will be…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Japan
The Japanese GI endoscopy device market is projected to experience modest expansion through 2034. This growth is driven by favorable treatment and screening guidelines, as well as an aging…